Skip to main content

Search

34 result(s) for 'author#Jean Chastre' within BMC

Page 1 of 2

Sort by: Relevance | Date

  1. The potential interest of antifungal treatment of non-immunocompromized patients with sepsis, extra-digestive Candida colonization and multiple organ failure is unknown. It represents three-quarters of antifungal...

    Authors: Jean-François Timsit, Elie Azoulay, Muriel Cornet, Jean-Pierre Gangneux, Vincent Jullien, Aurélien Vésin, Edith Schir and Michel Wolff
    Citation: Trials 2013 14:399
  2. Ventilator-associated pneumonia caused by Pseudomonas aeruginosa (PA) in hospitalised patients is associated with high mortality. The effectiveness of the bivalent, bispecific mAb MEDI3902 (gremubamab) in prevent...

    Authors: Jean Chastre, Bruno François, Marc Bourgeois, Apostolos Komnos, Ricard Ferrer, Galia Rahav, Nicolas De Schryver, Alain Lepape, Iftihar Koksal, Charles-Edouard Luyt, Miguel Sánchez-García, Antoni Torres, Philippe Eggimann, Despoina Koulenti, Thomas L. Holland, Omar Ali…
    Citation: Critical Care 2022 26:355
  3. The aim of this study was to compare a 7-day course of doripenem to a 10-day course of imipenem-cilastatin for ventilator-associated pneumonia (VAP) due to Gram-negative bacteria.

    Authors: Marin H Kollef, Jean Chastre, Marc Clavel, Marcos I Restrepo, Bart Michiels, Koné Kaniga, Iolanda Cirillo, Holly Kimko and Rebecca Redman
    Citation: Critical Care 2012 16:R218
  4. Ventilator-associated pneumonia (VAP) may contribute to the mortality associated with acute respiratory distress syndrome (ARDS). We aimed to determine the incidence, outcome, and risk factors of bacterial VAP...

    Authors: Jean-Marie Forel, François Voillet, Daniel Pulina, Arnaud Gacouin, Gilles Perrin, Karine Barrau, Samir Jaber, Jean-Michel Arnal, Mohamed Fathallah, Pascal Auquier, Antoine Roch, Elie Azoulay and Laurent Papazian
    Citation: Critical Care 2012 16:R65
  5. The incidence of nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus strains (MRSA) is on the rise worldwide. For years, vancomycin has been used as the drug of choice in the treatment of M...

    Authors: Mathias W Pletz, Olaf Burkhardt and Tobias Welte
    Citation: European Journal of Medical Research 2010 15:507
  6. Combination antibiotic therapy for ventilator associated pneumonia (VAP) is often used to broaden the spectrum of activity of empirical treatment. The relevance of such synergy is commonly supposed but poorly ...

    Authors: Pierre Damas, Christophe Garweg, Mehran Monchi, Monique Nys, Jean-Luc Canivet, Didier Ledoux and Jean-Charles Preiser
    Citation: Critical Care 2006 10:R52
  7. The results of a recently published Canadian study suggest that bronchoalveolar lavage and endotracheal aspiration are associated with similar clinical outcomes and similar overall use of antibiotics in critic...

    Authors: Jean-Yves Fagon, Jean Chastre and Jean-Jacques Rouby
    Citation: Critical Care 2007 11:123
  8. Hospital-acquired and ventilator-associated pneumonia (HAP/VAP) are often selected for randomized clinical trials (RCTs) aiming at new drug approval. Guidelines for the design of such RCTs have been repeatedly...

    Authors: Emmanuel Weiss, Wafa Essaied, Christophe Adrie, Jean-Ralph Zahar and Jean-François Timsit
    Citation: Critical Care 2017 21:162
  9. Bleeding is the most frequent complication in patients receiving venoarterial or venovenous extracorporeal membrane oxygenation (ECMO). Recombinant activated factor VII (rFVIIa) has been used in these patients...

    Authors: Xavier Repessé, Siu Ming Au, Nicolas Bréchot, Jean-Louis Trouillet, Pascal Leprince, Jean Chastre, Alain Combes and Charles-Edouard Luyt
    Citation: Critical Care 2013 17:R55
  10. There is little descriptive data on Stenotrophomonas maltophilia hospital-acquired pneumonia (HAP) in critically ill patients. The optimal modalities of antimicrobial therapy remain to be determined. Our objectiv...

    Authors: Philippe Guerci, Hugo Bellut, Mokhtar Mokhtari, Julie Gaudefroy, Nicolas Mongardon, Claire Charpentier, Guillaume Louis, Parvine Tashk, Clément Dubost, Stanislas Ledochowski, Antoine Kimmoun, Thomas Godet, Julien Pottecher, Jean-Marc Lalot, Emmanuel Novy, David Hajage…
    Citation: Critical Care 2019 23:371
  11. The rapid emergence and dissemination of antimicrobial-resistant microorganisms in ICUs worldwide constitute a problem of crisis dimensions. The root causes of this problem are multifactorial, but the core iss...

    Authors: Charles-Edouard Luyt, Nicolas Bréchot, Jean-Louis Trouillet and Jean Chastre
    Citation: Critical Care 2014 18:480